Clicky

BeiGene Ltd(49BA) News

Date Title
May 27 Sector Update: Health Care Stocks Rise Premarket Tuesday
May 27 BeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global Oncology
May 27 BeiGene Says EU Panel Recommends Tevimbra as Treatment for Nasopharyngeal Cancer
May 27 BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Nasopharyngeal Cancer
May 22 Exploring US High Growth Tech Stocks In May 2025
May 22 BeiGene Presents Pioneering Cancer Research at ASCO 2025 – Redefining Treatment Across Hematology and Solid Tumors
Apr 5 BeiGene (NasdaqGS:ONC) Gains 32% In A Quarter Amid Positive EMA Opinion On TEVIMBRA
Feb 17 HRMY or ONC: Which Is the Better Value Stock Right Now?
Feb 13 BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27
Feb 12 Is There An Opportunity With BeiGene, Ltd.'s (NASDAQ:ONC) 41% Undervaluation?
Dec 30 BeiGene’s Tevimbra approved in US for first-line gastric cancer treatment